BP
BioCryst Pharmaceuticals Inc
🇺🇸XNAS.BCRXUnited StatesHealthcare
$8.22USDup +0.06 (+0.74%)OpenDelayed4:20 PM
Price$8.22+0.06 (+0.74%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US09058V1035
- CUSIP
- 09058V103
Company
- Employees
- 435
- Headquarters
- Durham, United States
- Website
- https://www.biocryst.com
- CEO
- Mr. Charles K. Gayer
Market
- Shares outstanding
- 255.5M
- Market cap
- $2.1B
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $2.09B
- EPS LTM
- -$1.51calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -5.46calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $940.61M+68.72%up year on year
- Net income
- -$384.67M-977.18%down year on year
- Gross margin
- 23.52%-75.76%down year on year
- Free cash flow
- $357.11M+2,165.77%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.